Loading...

OTC Markets

Totals

Securities

12,304

Dollar Vol

$3.1B

Share Vol

4.8B

Trades

376,639

OTC Markets Group uses cookies and similar technologies to help us understand how you use our websites, as further disclosed in our Privacy Policy. Our Terms of Service contain important information including restrictions on your use of our websites. By clicking “Accept”, or by continuing to use our websites, you consent to the use of cookies and agree to the terms of the OTC Markets Group Privacy Policy and Terms of Service.

Market Activity
Stock
RSPI
Company Profile

RSPI
RespireRx Pharmaceuticals Inc.

Common Stock

RespireRx Pharmaceuticals Inc.

126 Valley Road

Suite C

Glen Rock, NJ 07452

www.respirerx.com

(201) 444-4947

jmargolis@respirerx.com

Last Verified 05/2022

Business Description

RespireRX Pharmaceuticals Inc. is a biopharmaceutical company focused on the discovery and development of novel drug therapies for the treatment of sleep apnea, ADHD, spinal cord injury and other neurological conditions.

Financial Reporting

Reporting Status

U.S. Reporting: SEC Reporting

Audited Financials

Audited

Latest Report

01/18/2024 8K Report

CIK

0000849636

Fiscal Year End

12/31

Company Officers & Contacts

Jeff E. Margolis

CFO, Senior VP, Secretary

David Dickason

SVP, Product Dev.

Richard D. Purcell, Jr.

SVP, R&D

Arnold S. Lippa

CSO, Interim CEO

Board of Directors

Arnold S. Lippa

Chairman, CSO, Interim CEO

Kathryn MacFarlane

Jeff E. Margolis

Other Company Insiders

None

Other Company Insiders are all persons or entities beneficially owning 10% or more of any class of the issuer's securities. Together, officers, directors and other company insiders comprise Company Insiders.

Service Providers

Accounting/Auditing Firm

Haskell & White LLP

300 Spectrum Drive

Suite 300

Irvine, CA 92618

Investment Bank

Primary Capital LLC

80 Wall Street

5th Floor

New York, NY 10005

Securities Counsel

DLA Piper - New Jersey

Profile Data

SIC - Industry Classification

2834 - Pharmaceutical preparations

Incorporation Information

DE, US, 1987

Employees

2 as of 09/20/2021

Shell

Products and Services

The Company is engaged in research and development of pharmaceutical products and does not have principal products.

Company Facilities

The company is primarily virtual and maintains an administrative office in Glen Rock, NJ. The company does not own the facility. The company does not maintain any other facilities. All employees and contractors work from remote locations.

Company Notes

Formerly=Cortex Pharmaceuticals, Inc. until 1-2016